These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30358837)

  • 1. Clostridioides difficile incidence related to in-hospital cephalosporin use: a tale of two highly comparable hospitals.
    Karp J; Edman-Wallér J; Toepfer M; Lundqvist A; Jacobsson G
    J Antimicrob Chemother; 2019 Jan; 74(1):182-189. PubMed ID: 30358837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cephalosporins in the era of Clostridium difficile infection.
    Wilcox MH; Chalmers JD; Nord CE; Freeman J; Bouza E
    J Antimicrob Chemother; 2017 Jan; 72(1):1-18. PubMed ID: 27659735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
    Kazakova SV; Baggs J; McDonald LC; Yi SH; Hatfield KM; Guh A; Reddy SC; Jernigan JA
    Clin Infect Dis; 2020 Jan; 70(1):11-18. PubMed ID: 30820545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for recurrent healthcare-facility associated Clostridioides difficile infection in a Swedish setting.
    Karp J; Edman-Wallér J; Toepfer M; Jacobsson G
    Anaerobe; 2023 Jun; 81():102738. PubMed ID: 37217115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
    Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
    Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
    J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile in an Urban, University-Affiliated Long-Term Acute-Care Hospital.
    Jacob J; Wu J; Han J; Nelson DB
    Infect Control Hosp Epidemiol; 2017 Mar; 38(3):294-299. PubMed ID: 27923419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
    Lambert PJ; Dyck M; Thompson LH; Hammond GW
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
    Price J; Cheek E; Lippett S; Cubbon M; Gerding DN; Sambol SP; Citron DM; Llewelyn M
    Clin Microbiol Infect; 2010 Aug; 16(8):1297-302. PubMed ID: 19832710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Antibiotic Consumption and Incidence of
    Kim B; Kim J; Pai H
    J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Community and Healthcare-onset Clostridium difficile Infections.
    Mora Pinzon MC; Buie R; Liou JI; Shirley DK; Evans CT; Ramanathan S; Poggensee L; Safdar N
    Clin Infect Dis; 2019 Apr; 68(8):1343-1350. PubMed ID: 30668844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Clostridium difficile infection in Portugal: Experience at a tertiary care hospital.
    Sintra S; Taveira F; Canha C; Carvalho A; Simão A
    Eur J Intern Med; 2019 Feb; 60():e11-e13. PubMed ID: 30343987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions.
    Ostrowsky B; Ruiz R; Brown S; Chung P; Koppelman E; van Deusen Lukas C; Guo Y; Jalon H; Sumer Z; Araujo C; Sirtalan I; Brown C; Riska P; Currie B
    Infect Control Hosp Epidemiol; 2014 Oct; 35 Suppl 3():S86-95. PubMed ID: 25222903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital-level high-risk antibiotic use in relation to hospital-associated
    Tabak YP; Srinivasan A; Yu KC; Kurtz SG; Gupta V; Gelone S; Scoble PJ; McDonald LC
    Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1229-1235. PubMed ID: 31522695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.